RECRUITING

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

Talk to us

Conditions

Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study is testing whether changes in sleep timing and morning light treatment may have an impact on symptoms related to inflammatory bowel disease.

Official Title

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

Quick Facts

Study Start:2024-02-01
Study Completion:2026-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06094608

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Biopsy-proven IBD
  2. * Active IBD symptoms
  3. * Impaired IBD quality of life
  4. * Age \>/=18 years old
  5. * Fluency in English
  6. * Physically able to travel for study visits
  1. * Ileostomy, colostomy, ileoanal pouch, or ileorectal anastomoses, are planned for imminent surgery and/or have short bowel syndrome
  2. * Other significant chronic disease
  3. * Retinal pathology, history of eye surgery, taking photosensitizing medications
  4. * Recent history of light treatment
  5. * Lifetime psychotic or bipolar disorder
  6. * Acute suicidal ideation
  7. * Substance use disorder in the past 3 months, cannabis use \>1/week
  8. * High risk for or diagnosed with obstructive sleep apnea, and/or narcolepsy
  9. * Severe hearing problem, intellectual disability or serious cognitive impairment
  10. * Pregnant, trying to get pregnant, or breastfeeding
  11. * Night work or travel outside the eastern time zone in the past month

Contacts and Locations

Study Contact

Muneer Rizvydeen
CONTACT
Phone 734-232-9281
ibd-sleep@med.umich.edu

Principal Investigator

Helen Burgess, Ph.D.
PRINCIPAL_INVESTIGATOR
University of Michigan
Cathy Goldstein, M.D., M.S.
PRINCIPAL_INVESTIGATOR
University of Michigan

Study Locations (Sites)

University of Michigan
Ann Arbor, Michigan, 48105
United States

Collaborators and Investigators

Sponsor: University of Michigan

  • Helen Burgess, Ph.D., PRINCIPAL_INVESTIGATOR, University of Michigan
  • Cathy Goldstein, M.D., M.S., PRINCIPAL_INVESTIGATOR, University of Michigan

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-01
Study Completion Date2026-05-31

Study Record Updates

Study Start Date2024-02-01
Study Completion Date2026-05-31

Terms related to this study

Additional Relevant MeSH Terms

  • Inflammatory Bowel Diseases
  • Ulcerative Colitis
  • Crohn Disease